Uri Ben‐David
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Molecular Biology top 2%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Renal and related cancers
Papers in
-
- Cancer Genomics and Diagnostics 15
-
- Pluripotent Stem Cells Research 27
- CRISPR and Genetic Engineering 20
- Renal and related cancers 8
- Genomics and Chromatin Dynamics 5
- Co-authors
- Nissim Benvenisty (21 shared papers)Angelika Amon (3 shared papers)Yoav Mayshar (5 shared papers)Rameen Beroukhim (5 shared papers)Todd R. Golub (5 shared papers)Amander T. Clark (2 shared papers)William E. Lowry (2 shared papers)Neta Lavon (1 shared paper)
- Journals
- Cell stem cell (9 papers)Nature Communications (7 papers)Nature Genetics (4 papers)Cancer Discovery (3 papers)npj Precision Oncology (3 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Uri Ben‐David
66 papers receiving 7.3k citations
Uri Ben‐David's Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 1.3k
- Molecular Biology 4.7k
- Genetics 634
- Oncology 1.3k
- Aging 80
Countries citing papers authored by Uri Ben‐David
This map shows the geographic impact of Uri Ben‐David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Ben‐David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Ben‐David more than expected).
Fields of papers citing papers by Uri Ben‐David
This network shows the impact of papers produced by Uri Ben‐David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Ben‐David. The network helps show where Uri Ben‐David may publish in the future.
Co-authors
The 25 scholars most cited alongside Uri Ben‐David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The tumorigenicity of human embryonic and induced pluripotent stem cells Hit paper breakdown → | 2011 | 738 |
| 2 | Genetic and transcriptional evolution alters cancer cell line drug response Hit paper breakdown → | 2018 | 653 |
| 3 | Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells Hit paper breakdown → | 2010 | 613 |
| 4 | Patient-derived xenografts undergo mouse-specific tumor evolution Hit paper breakdown → | 2017 | 586 |
| 5 | Discovering the anticancer potential of non-oncology drugs by systematic viability profiling Hit paper breakdown → | 2020 | 575 |
| 6 | Context is everything: aneuploidy in cancer Hit paper breakdown → | 2019 | 434 |
| 7 | 2016 | 406 | |
| 8 | 2013 | 272 | |
| 9 | 2020 | 226 | |
| 10 | 2011 | 214 | |
| 11 | 2021 | 195 | |
| 12 | 2011 | 194 | |
| 13 | 2018 | 168 | |
| 14 | 2014 | 159 | |
| 15 | 2022 | 155 | |
| 16 | 2013 | 143 | |
| 17 | 2021 | 131 | |
| 18 | 2023 | 120 | |
| 19 | 2014 | 118 | |
| 20 | 2015 | 109 |
About Uri Ben‐David
Uri Ben‐David is a scholar working on Cancer Research, Molecular Biology, Cell Biology, Genetics and Oncology, having authored 67 papers that have together received 7.5k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (27 papers), CRISPR and Genetic Engineering (20 papers), Cancer Genomics and Diagnostics (15 papers), Microtubule and mitosis dynamics (14 papers), Renal and related cancers (8 papers), 3D Printing in Biomedical Research (6 papers), Genomics and Chromatin Dynamics (5 papers) and Biomedical Ethics and Regulation (5 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (4.7k citations), Genetics (634 citations), Oncology (1.3k citations) and Aging (80 citations). Uri Ben‐David has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Nissim Benvenisty, Angelika Amon, Yoav Mayshar, Rameen Beroukhim, Todd R. Golub, Amander T. Clark, William E. Lowry, Neta Lavon, Kathrin Plath and Benjamin Yakir. Their work appears in journals such as Cell stem cell, Nature Communications, Nature Genetics, Cancer Discovery and npj Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.